journal article Dec 01, 1999

Neurotoxic effects of endocrine disruptors

View at Publisher Save 10.1097/00019052-199912000-00015
Topics

No keywords indexed for this article. Browse by subject →

References
75
[1]
Dohler vol (20)
[2]
McEwen Endocr Rev (1999) 10.1210/er.20.3.279
[3]
Woolley Curr Opin Neurobiol (1999) 10.1016/s0959-4388(99)80051-8
[4]
Woolley Crit Rev Neurobiol (1999) 10.1615/critrevneurobiol.v13.i1.10
[5]
Woolley Epilepsia (1998) 10.1111/j.1528-1157.1998.tb02601.x
[6]
vom Saal J Animal Sci (1989) 10.2527/jas1989.6771824x
[7]
McEwen Horm Behav (1977) 10.1016/0018-506x(77)90060-5
[8]
Toran-Allerand Frontiers Neuroendocrinol (1999) 10.1006/frne.1999.0177
[9]
Klein-Hitpass J Mol Med (1998) 10.1007/s001090050243
[10]
Couse J Mol Med (1998) 10.1007/s001090050244
[11]
Gottlicher J Mol Med (1998) 10.1007/s001090050242
[12]
Weigel J Mol Med (1998) 10.1007/s001090050241
[14]
McEwen J Clin Endocrinol Metab (1999) 10.1210/jc.84.6.1790
[15]
Brouwer Toxicol Indust Health (1998) 10.1177/074823379801400107
[16]
Kavlock Environ Health Perspect (1996) 10.2307/3432708
[17]
Kuiper Endocrinology (1998) 10.1210/en.139.10.4252
[18]
Bachmann Drug Chem Toxicol (1998) 10.3109/01480549809007402
[19]
Bicknell J Steroid Biochem Molec Biol (1995) 10.1016/0960-0760(95)00118-j
[20]
Faqi Bull Environ Contamination Toxicol (1998) 10.1007/s001289900785
[21]
Gustafsson vol (20)
[22]
Gorski Can J Physiol Pharmacol (1985) 10.1139/y85-098
[23]
Bloch J Comp Neurol (1988) 10.1002/cne.902750408
[24]
Gorski Brain Res (1978) 10.1016/0006-8993(78)90723-0
[25]
Rhees Dev Brain Res (1990) 10.1016/0165-3806(90)90217-m
[26]
Dohler Brain Res (1984) 10.1016/0006-8993(84)90242-7
[27]
McCarthy Endocrinology (1993) 10.1210/en.133.2.433
[28]
Davis Brain Res (1996) 10.1016/0006-8993(96)00298-3
[29]
Arai Neurosci Res (1996) 10.1016/0168-0102(96)01070-x
[30]
McCarthy Dev Neurosci (1997) 10.1159/000111246
[32]
Matsumoto Neurosci Lett (1986) 10.1016/0304-3940(86)90135-7
[33]
Matsumoto Neuroendocrinology (1986) 10.1159/000124445
[34]
Frankfurt Neuroendocrinology (1990) 10.1159/000125387
[35]
Woolley Horm Behav (1998) 10.1006/hbeh.1998.1466
[37]
Matsumoto Cell Tissue Res (1979) 10.1007/bf00234187
[38]
Matsumoto Neurosci Res (1985) 10.1016/0168-0102(85)90052-5
[39]
Mong J Neurosci (1999) 10.1523/jneurosci.19-04-01464.1999
[40]
Holene Behav Brain Res (1998) 10.1016/s0166-4328(97)00181-2
[41]
Frankfurt Neuroendocrinology (1991) 10.1159/000125975
[42]
Woolley J Neurosci (1997) 10.1523/jneurosci.17-05-01848.1997
[43]
Tilson Toxicol Lett (1998) 10.1016/s0378-4274(98)00271-9
[44]
Tilson Neurotoxicology (1998)
[45]
Fischer Toxicol Sci (1998)
[46]
MacLusky Toxicol Indust Health (1998) 10.1177/074823379801400112
[47]
Eriksson Neurotoxicology (1997)
[48]
Hany Neurotoxicol Teratol (1999) 10.1016/s0892-0362(98)00038-5
[49]
Seegal Toxicol Appl Pharmacol (1997) 10.1006/taap.1997.8226
[50]
Holene vol (429)

Showing 50 of 75 references

Metrics
13
Citations
75
References
Details
Published
Dec 01, 1999
Vol/Issue
12(6)
Pages
745-751
Cite This Article
Susan A. Laessig, Margaret M. McCarthy, Ellen K. Silbergeld (1999). Neurotoxic effects of endocrine disruptors. Current Opinion in Neurology, 12(6), 745-751. https://doi.org/10.1097/00019052-199912000-00015
Related

You May Also Like

Sex differences in autism spectrum disorders

Donna M. Werling, Daniel H. Geschwind · 2013

988 citations

Human brain networks in health and disease

Danielle S Bassett, Edward T Bullmore · 2009

787 citations

Pseudoprogression and pseudoresponse in the treatment of gliomas

Dieta Brandsma, Martin J van den Bent · 2009

318 citations

Premotor and nonmotor features of Parkinson's disease

Jennifer G. Goldman, Ron Postuma · 2014

296 citations